Patients perception of self-administrated medication in the treatment of hereditary angioedema

Adrian Wang, Andrew Fouche, Timothy Craig

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background Early therapy of hereditary angioedema (HAE) decreases morbidity, improves outcomes, decreases absenteeism, and possibly decreases mortality. This can be accomplished best with self-therapy. Previously, the authors examined barriers to self-therapy from the perspective of the nurse and the physician, but data are lacking on what patients perceive as major barriers to self-administered therapy for HAE. Objective To identify those barriers in a prospective fashion by patient interview. Methods After approval from the institutional review board, a telephone survey was performed of patients with HAE from a database of patients who were recently seen in the clinic. The survey focused on anxiety, depression, stress, concerns regarding method of administration, the ability to inject themselves, and what they perceived as barriers to providing self-care. Results Ninety-two patients were contacted and 59 agreed to participate. With 69% of those patients currently undergoing self-administered treatment, the results showed minimal depression and anxiety, a high satisfaction with treatment, and significant compliance with treatment. Most of those not yet on self-administered therapy wanted to start despite being satisfied with the care received in the emergency department. They also believed care at home would be optimal. The main concern of the 2 groups was not being able to treat themselves in the event of an HAE attack. Conclusion From these data, it is obvious that most patients are willing to self-treat. This suggests that physicians should encourage self-treatment of HAE to improve outcomes and quality of life of patients with HAE.

Original languageEnglish (US)
Pages (from-to)120-125
Number of pages6
JournalAnnals of Allergy, Asthma and Immunology
Volume115
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

Hereditary Angioedemas
Therapeutics
Anxiety
Depression
Physicians
Absenteeism
Aptitude
Research Ethics Committees
Home Care Services
Self Care
Secondary Prevention
Telephone
Hospital Emergency Service
Nurses
Quality of Life
Databases
Interviews
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

@article{898edf7b65a145ef910dbec45018e0e0,
title = "Patients perception of self-administrated medication in the treatment of hereditary angioedema",
abstract = "Background Early therapy of hereditary angioedema (HAE) decreases morbidity, improves outcomes, decreases absenteeism, and possibly decreases mortality. This can be accomplished best with self-therapy. Previously, the authors examined barriers to self-therapy from the perspective of the nurse and the physician, but data are lacking on what patients perceive as major barriers to self-administered therapy for HAE. Objective To identify those barriers in a prospective fashion by patient interview. Methods After approval from the institutional review board, a telephone survey was performed of patients with HAE from a database of patients who were recently seen in the clinic. The survey focused on anxiety, depression, stress, concerns regarding method of administration, the ability to inject themselves, and what they perceived as barriers to providing self-care. Results Ninety-two patients were contacted and 59 agreed to participate. With 69{\%} of those patients currently undergoing self-administered treatment, the results showed minimal depression and anxiety, a high satisfaction with treatment, and significant compliance with treatment. Most of those not yet on self-administered therapy wanted to start despite being satisfied with the care received in the emergency department. They also believed care at home would be optimal. The main concern of the 2 groups was not being able to treat themselves in the event of an HAE attack. Conclusion From these data, it is obvious that most patients are willing to self-treat. This suggests that physicians should encourage self-treatment of HAE to improve outcomes and quality of life of patients with HAE.",
author = "Adrian Wang and Andrew Fouche and Timothy Craig",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.anai.2015.06.006",
language = "English (US)",
volume = "115",
pages = "120--125",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "2",

}

Patients perception of self-administrated medication in the treatment of hereditary angioedema. / Wang, Adrian; Fouche, Andrew; Craig, Timothy.

In: Annals of Allergy, Asthma and Immunology, Vol. 115, No. 2, 01.01.2015, p. 120-125.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Patients perception of self-administrated medication in the treatment of hereditary angioedema

AU - Wang, Adrian

AU - Fouche, Andrew

AU - Craig, Timothy

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background Early therapy of hereditary angioedema (HAE) decreases morbidity, improves outcomes, decreases absenteeism, and possibly decreases mortality. This can be accomplished best with self-therapy. Previously, the authors examined barriers to self-therapy from the perspective of the nurse and the physician, but data are lacking on what patients perceive as major barriers to self-administered therapy for HAE. Objective To identify those barriers in a prospective fashion by patient interview. Methods After approval from the institutional review board, a telephone survey was performed of patients with HAE from a database of patients who were recently seen in the clinic. The survey focused on anxiety, depression, stress, concerns regarding method of administration, the ability to inject themselves, and what they perceived as barriers to providing self-care. Results Ninety-two patients were contacted and 59 agreed to participate. With 69% of those patients currently undergoing self-administered treatment, the results showed minimal depression and anxiety, a high satisfaction with treatment, and significant compliance with treatment. Most of those not yet on self-administered therapy wanted to start despite being satisfied with the care received in the emergency department. They also believed care at home would be optimal. The main concern of the 2 groups was not being able to treat themselves in the event of an HAE attack. Conclusion From these data, it is obvious that most patients are willing to self-treat. This suggests that physicians should encourage self-treatment of HAE to improve outcomes and quality of life of patients with HAE.

AB - Background Early therapy of hereditary angioedema (HAE) decreases morbidity, improves outcomes, decreases absenteeism, and possibly decreases mortality. This can be accomplished best with self-therapy. Previously, the authors examined barriers to self-therapy from the perspective of the nurse and the physician, but data are lacking on what patients perceive as major barriers to self-administered therapy for HAE. Objective To identify those barriers in a prospective fashion by patient interview. Methods After approval from the institutional review board, a telephone survey was performed of patients with HAE from a database of patients who were recently seen in the clinic. The survey focused on anxiety, depression, stress, concerns regarding method of administration, the ability to inject themselves, and what they perceived as barriers to providing self-care. Results Ninety-two patients were contacted and 59 agreed to participate. With 69% of those patients currently undergoing self-administered treatment, the results showed minimal depression and anxiety, a high satisfaction with treatment, and significant compliance with treatment. Most of those not yet on self-administered therapy wanted to start despite being satisfied with the care received in the emergency department. They also believed care at home would be optimal. The main concern of the 2 groups was not being able to treat themselves in the event of an HAE attack. Conclusion From these data, it is obvious that most patients are willing to self-treat. This suggests that physicians should encourage self-treatment of HAE to improve outcomes and quality of life of patients with HAE.

UR - http://www.scopus.com/inward/record.url?scp=84938738251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938738251&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2015.06.006

DO - 10.1016/j.anai.2015.06.006

M3 - Article

VL - 115

SP - 120

EP - 125

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 2

ER -